Skip to content
Forgedrive UK

Individuals Discontinuing Weight-Loss Medications Put On Weight Far More Rapidly Than People Using Diet and Exercise

Illustration of medical injection and scale
Obesity treatment involves long-term strategies.

A recent study suggests that individuals who come off blockbuster weight-loss injections like Mounjaro or Wegovy tend to recover shed pounds far faster than those who stop conventional lifestyle regimens.

Findings released in a major medical journal shows that while overweight people frequently drop substantial amounts of their total mass while undergoing treatment, the weight is regained at an average rate of 0.8 kg per month upon discontinuation.

"Users buying such drugs should be cognizant of the risk of fast weight regain when the therapy concludes," stated researcher Dr. Susan Jebb.

That rate of regain suggests a return to pre-treatment mass in about 18 months.

Comparing Approaches

The analysis, which reviewed 37 of trials involving over 9,000 of participants, contrasted the effects of the injectable medications with other pills.

The team note that people who shed pounds through lifestyle changes alone typically experience a less rapid weight regain—approximately 100 grams monthly—post-intervention.

The Reason for the Fast Regain

Nutrition scientists propose the mode of action of the injections is key to understanding the accelerated regain.

GLP-1 drugs mimic a natural hormone called glucagon-like peptide-1, which controls feelings of fullness.

"Artificially providing the hormone concentrations several times higher than normal might result in the body to produce less of its own natural GLP-1, and may also diminish sensitivity to its effects," explained Dr. Adam Collins, a dietetics specialist.

"Withdrawal of this medication means hunger is uncontrolled, making overeating far more likely."

A Chronic Condition?

Health authorities suggest the jabs for people with obesity-related health risks, accompanied by recommended lifestyle changes.

A number of clinicians say that, given the likelihood of weight regain, the therapy might need to be life-long.

This view is supported by drug manufacturers, who say that the results "highlight the persistent character of excess weight," akin to managing conditions like hypertension.

User Accounts

People who have discontinued the medication describe a sudden resurgence of appetite.

"I experienced a switch activating and you're instantly extremely hungry," described an individual.

This difficulty is compounded if patients have not adopted permanent lifestyle or habit changes during treatment.

Significant Interest

Recent estimates indicate that a significant number of people in the UK have used these injections in the past year, with demand remaining high.

  • Adoption is more common among women than males.
  • The 40s and 50s age group shows the highest level of interest.
  • Many obtain the medications through private prescriptions rather than the NHS.

Ultimately, researchers emphasize that while the jabs are potent agents for shedding pounds, they are not a standalone fix and maintained weight loss likely depends on ongoing behavioural changes.

SP
Written by

Sean Pham

Marcus Thorne is a seasoned automotive engineer with over 15 years of experience in performance tuning and forged component design, passionate about enhancing vehicle dynamics.

Forgedrive UK

Type to search articles.